Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2009 Oct 1.
Published in final edited form as: J Inorg Biochem. 2008 Jul 5;102(10):1901–1909. doi: 10.1016/j.jinorgbio.2008.06.014

Structural Differences Between Pb2+- and Ca2+-binding Sites in Proteins: Implications with Respect to Toxicity

Michael Kirberger 1, Jenny J Yang 1
PMCID: PMC2567809  NIHMSID: NIHMS70411  PMID: 18684507

Abstract

Pb2+ is known to displace physiologically-relevant metal ions in proteins. To investigate potential relationships between Pb2+/protein complexes and toxicity, data from the Protein Data Bank were analyzed to compare structural properties of Pb2+- and Ca2+-binding sites. Results of this analysis reveal that the majority of Pb2+ sites (77.1%) involve 2 to 5 binding ligands, compared with 6 ± 2 for non-EF-Hand and 7 ± 1 for EF-Hand Ca2+-binding sites. The mean net negative charge by site (1.7) fell between values noted for non-EF-Hand (1 ± 1) and EF-Hand (3 ± 1). Oxygen is the dominant ligand for both Pb2+ and Ca2+, but Pb2+ binds predominantly with sidechain Glu (38.4%), which is less prevalent in both non-EF-Hand (10.4%) and EF-Hand (26.6%) Ca2+-binding sites. A comparison of binding geometries where Pb2+ has replaced Ca2+ in calmodulin (CaM) and Zn2+ in 5-aminolaevulinic acid dehydratase (ALAD) revealed protein structural changes that appear to be unrelated to ionic displacement. Structural changes observed with CaM may be related to opportunistic binding of Pb2+ in regions of high electrostatic charge, whereas ALAD may bind multiple Pb2+ ions in the active site. These results suggest that Pb2+ adapts to structurally-diverse binding geometries and that opportunistic binding may play an active role in molecular metal toxicity.

Keywords: Metalloprotein, toxicity, electrostatic, opportunistic binding, misfolding

1 Introduction

Complex formation between inorganic metals and proteins is essential to numerous biological processes, where binding of physiologically-relevant metals (e.g. – Ca, Mg, Zn, Fe) effects conformational changes that confer new functions. Nearly 40% of all proteins are known to bind metals [1-6]. Metal-binding sites in general are characterized by a central shell of hydrophilic chelating ligands, with a surrounding shell of hydrophobic residues [7, 8], and the binding geometry, coordination number, and ligand preference associated with the binding of essential metal ions to natural proteins has been studied extensively [4, 914].

Ca2+-binding proteins (CaBPs) represent a large family of these metalloproteins. Calmodulin (CaM) is an important CaBP, widely-distributed among eukaryotes, that binds up to four Ca2+ ions (Fig. 1a) with continuous EF-hand motifs. The resulting Ca2+-CaM complex mediates biological processes related to inflammation, muscle contraction, memory, nerve growth and the immune response, and may act as a sensor/signal transducer when it binds with proteins unable to bind Ca2+ themselves [15, 16]. Ca2+ may also interact with proteins to regulate functions related to cell division, apoptosis and intracellular signaling [1720], as well as to enhance protein stability [21].

Fig. 1.

Fig. 1

Proteins 1exr (a), Ca-bound calmodulin, and 1n0y (b), Pb-bound calmodulin. EF-1 through EF-IV indicates Ca2+-binding sites. (c) Four Pb2+ ions (circle) opportunistically bound along groove between chains in 1n0y. (d) Electrostatic potential surface map of 1n0y rendered with GRASP, showing region of negative charge density (circle) where Pb2+ ions are bound.

The coordination chemistry of proteins that facilitates binding of essential metal ions also makes them susceptible to interaction with toxic metals. In addition to Pb2+, Sr2+, Hg2+ and Cd2+, most lanthanides have been found to bind with both natural and engineered CaBPs [2226], and many of these can activate and then inhibit CaM in response to changes in metal concentration, thus altering the activity of downstream CaM-mediated functions [2732]. Additionally, several recent studies have reported bacterium capable of encoding sensor or chelate proteins for toxic metals [3335], including Ralstonia metallidurans, which possesses the first identified bacterial resistance determinant found to be specific for Pb2+ [36].

Despite rigorous studies aimed at understanding the structural implications of metal-binding for physiologically-relevant metals, the binding characteristics of toxic metals like lead (Pb2+) are less clearly defined. Pb2+ is a particularly persistent anthropogenic toxicant whose bioavailability has increased as a result of human industry. Physiological effects of Pb2+ uptake include neurological disorders, anemia, kidney damage, hypertension and male fertility decrease [3742]. At the molecular level, Pb2+ has been shown to specifically target voltage-gated calcium channels [43]; activate skeletal muscle troponin C (TnC) [44]; and displace both Ca2+ and Zn2+ in proteins, including CaM, protein kinase C [45], and synaptotagmin [46]. Several studies have indicated that a thiol-rich site binds Pb2+ in a distorted trigonal pyramidal geometry with 3 ligands, or alternatively with a geometry including 5–8 ligands, which differs from reported coordination numbers for Zn2+ of either 4–6 or 8 ligands [4752]. Both carboxyl- and cysteine-rich sites associated with the binding of Pb2+ are reported with toxic metal-sensing proteins, where the latter binding sites include 3–4 cysteine residues, arranged in either a distorted tetrahedral or a trigonal coordination geometry [33, 35].

To further our understanding of Pb2+ toxicity at the molecular level, we report a quantitative analysis of all Pb2+-protein complexes listed in the Protein Data Bank (PDB) to evaluate structural characteristics associated with binding. Two structures of CaM from the species Paramecium tetraurelia (Fig. 1a, Fig. 1b), the only protein currently in the PDB with both Ca2+- and Pb2+- loaded forms, are compared to evaluate physical characteristics associated with binding of the different ions. CaM was specifically analyzed in this study for three reasons. First, it is an essential signaling protein involved in over 100 biological processes and has been studied extensively [5356]. Second, two significant studies, using different spectroscopic methods, have reported high affinity binding of Pb2+ in CaM [57, 58]. This potential for high affinity binding in concert with the essential role of calmodulin involved in various biological processes and calcium signaling may represent an important link to Pb2+ toxicity at the molecular level which can be revealed through detailed structural analysis. Third, CaM contains four EF-hand motifs. First described by Kretsinger in 1973 [59], this common Ca2+-binding motif found in more than 50% of all CaBPs is characterized by a sequence of approximately 30 amino acids arranged in a helix-loop-helix structure with a pentagonal-bipyramid geometry (Fig. 2a) [60, 61]. Recent work in our lab has confirmed the displacement of Ca2+ by Pb2+ in isolated CaM loops [M. Kirberger and J.J. Yang, manuscript in preparation]. A similar analysis was also completed with two structures of yeast 5-aminolaevulinic acid dehydratase (ALAD) bound with Zn2+ and Pb2+.

Fig. 2.

Fig. 2

(a) Pentagonal-bipyramidal geometry typical of well-ordered EF-Hand Ca2+-binding site. (b) Holodirected and (c) hemidirected binding coordination schemes for Pb2+ proposed by Shimoni-Livny et al [70]. (d) Frequency distribution of CN values, with and without water, for DS HR and DS Final.

Analysis of data presented in this study led us to hypothesize that while ionic displacement of Ca2+ by a competing metal ion may represent one mechanism of metal toxicity, an additional opportunistic binding mechanism, resulting from metal-protein interactions in regions lacking an established binding site and related to electrostatic potential interactions, may represent an additional avenue for metal toxicity. Both mechanisms may offer partial explanations for the activation/inhibition of CaM activity reported in related studies [2732].

2 Materials and Methods

A preliminary search of the Protein Data Bank (http://www.rcsb.org/pdb/) identified 27 PDB files for proteins known to bind Pb2+. Six of these were discarded as they represented either duplicate structures or nucleic acid structures. From the remaining 21 PDB files, 20 of the 68 Pb2+ binding sites were eliminated due to redundancy associated with polymeric domains, or because the only binding ligands associated with the ion were water molecules, leaving 48 binding sites retained for the analysis (Table S1).

Although possible Pb-O and Pb-N binding distances as long as 4.2 Å have been reported in the literature [62], we chose a shorter ligand inclusion cutoff distance of 3.5 Å from the Pb2+ ion for several reasons. First, 75% of the ligands identified by the analysis fell within the 3.5 Å cutoff distance, including all of the ligands where binding resulted from displacement of another ion. Second, work by Harding and others [62, 63] has suggested a variable region approximately between 3.2 – 4.0 Å where the distribution of ligands for certain metal ions decreases significantly, and begins to increase again near 4.0 Å. This corresponds with second shell interaction ranges reported by Dudev [11], where first shell interactions are constrained to 3.5 Å. This cutoff distance is also frequently cited as the upper limit for Ca2+ binding; however, nearly all studies of Ca2+, including a recent study completed in our laboratory, have demonstrated that Ca2+-binding ligands are generally within 2.9 Å distance from the ion [4, 10, 63, 64]. In the case of Pb2+ which has a slightly larger radius than Ca2+, we allowed for the possibility that the larger radius would result in minor increases in binding distance values, which is accommodated by the 3.5 Å cutoff.

Of the 177 ligand atoms retained for the analysis, only five have occupancy values less than 1 (i.e. - more than one stable set of coordinates was observed for the atom in the crystalline structure), and these atoms were not removed as their inclusion would not significantly alter the analysis. Two datasets were then constructed for evaluation: a final dataset (DS Final) comprised of all retained binding sites, and a subset comprised of higher resolution (DS HR) structural data (R less than 1.76 Å), to limit error inherent in structures with lower resolution [65].

Data from the Ligand Protein Contact Data Server (LPC) (http://bioportal.weizmann.ac.il/oca-bin/lpccsu) were obtained to verify binding ligands. Data from the PDB were selectively filtered using a custom, Visual Basic (Microsoft Corporation, Redmond, WA) program, then loaded into an Access relational database. Statistical data on binding ligands were extracted from the database using Structured Query Language (SQL) queries to identify all potential oxygen, nitrogen or sulfur ligand atoms within 3.5 Å of the target Pb2+ ions. Distance was calculated based on Equation 1, where (XLigand – XPb) indicates the spatial difference between each component’s numerical coordinate along the X-axis. The differences for each component along the Y and Z axis are calculated in the same manner.

Distance=((XLigandXPb)2+(YLigandYPb)2+(ZLigandZPb)2)1/2 (Equation 1)

Additionally, 54 potential bidentate ligand pairs in the PDB files were inspected using Pymol [66], and 36 were visually-identified as bidentate pairs. For these, a bidentate ligand propensity property Lβ (Equation 2) was defined based on the ratio (d1/d2) where d1 represents the distance between Pb2+ and either Asp OD1 or Glu OE1, and d2 represents the distance between Pb2+ and either Asp OD2 or Glu OE2.

Lβ=(d1/d2) (Equation 2)

The geometric ratio (d1/d2, or Lβ) describes the deviation from unity for a theoretically-symmetric bidentate ligand group. This deviation increases as the denticity moves from bidentate to monodentate. Because d1 may be either greater than or less than d2, calculation of Lβ for multiple bidentate ligands produces a value range with a central point near 1 (i.e. – unity). The Lβ range determined for Pb2+-binding was found to be 1.04 ± 0.29, which differs from that calculated for Ca2+ (1.07 ± 0.34), and we expect to observe small, metal-specific variations. The significance of this property is that it can be utilized in related analyses to predict bidentate ligands from structural data, without the necessity of viewing each individual model. Further detailed information describing the empirical derivation of this property is described in a related publication [M. Kirberger and J.J. Yang, manuscript in preparation].

Comparative data for Ca2+-binding was also obtained from the Protein Data Bank, where a total of 1605 binding sites from 558 PDB files with resolution R ≤ 2.0 Å were retained for the analysis, based on a cutoff distance of 3.5 Å as the maximum ligand distance for oxygen and nitrogen, and following removal of structures with greater than 90% sequence homology.

3 Results and Discussion

Table S2 lists the retained binding sites, their PDB identifiers, coordination number (CN) values both with (PLW) and without (PL) water molecules, formal charge (FC), and binding mode (D – displacement, O – opportunistic, or U - unknown) by site. As seen in Table S2, approximately 1/3 of the Pb2+-binding sites were identified as sites of ionic displacement, indicating that these sites are also known to bind physiologically-relevant ions, as listed in the Binding column. Statistical analysis of these two separate binding modes was not performed in this study due to limited data for each of the different metals listed.

Binding sites from the high-resolution dataset (DS HR) are identified by an asterisk preceding the PDB_ID. A charge of (−1) was assigned to acidic side-chain ligands Glu and Asp, and the Cys thiol [67]. Table 1 presents a summary of all statistical data from the analysis. A comparison of the values reported for DS HR and DS Final show little difference in ligand distance values, coordination number, and charge, indicating that resolution did not significantly alter the results. Consequently, unless otherwise specified, results from only the DS Final dataset are discussed from the analysis. These statistical results for Pb2+ are then compared with data recently compiled for Ca2+ to emphasize differences in binding characteristics exhibited by the two metals.

Table 1.

Pb2+-binding statistics.

DS HR DS Final
Total PDB proteins in study 7 21
Total Pb binding sites evaluated 27 48
Total target ligand atoms 105 177
Total Oaa ligands 86 118
Total OHOH ligands 16 36
Total N ligands 3 10
Total S ligands 0 13
Total sites with N ligands 3 9
Mean CN, PLW 3.9 ± 2.3 3.7 ± 2.0
% CN 2–5 77.8 77.1
% CN 6–9 22.2 16.7
Mean CN, PL 3.3 ± 2.0 2.9 ± 1.7
% CN 2–5 70.4 72.9
% CN 6–9 14.8 8.3
Mean charge by site −1.8 −1.7
Total identified bidentate pairs 24 36
Total sites with bidentate ligands 21 30
% Sites with bidentate ligands 77.8 62.5
Mean distance, Pb-Oaa, (Å) 2.7 ± 0.4 2.7 ± 0.4
Mean distance, Pb-OHOH, (Å) 2.8 ± 0.3 2.8 ± 0.4
Mean distance, Pb-N (Å) 2.7 ± 0.3 2.6 ± 0.4
Mean distance, Pb-S (Å) --- 3.2 ± 0.3

DS HR: High resolution dataset (equal to or better than 1.75 Å), 3.5 Å ligand-atom distance cut off. DS Final: Summary dataset, no restriction on resolution, 3.5 Å ligand-atom distance cut off, refined for bidentate ligands. CN: Coordination Number. PLW: Ligands from protein and water. PL: Ligands from protein only. Oaa: Amino acid oxygen ligand. OHOH: Water oxygen ligand.

3.1 Ligand Coordination by Binding Site

The coordination numbers presented in Table 1 are differentiated based on the inclusion or exclusion of water oxygen ligands. For the DS Final dataset, mean CN values were reported as 2.9 ± 1.7 and 3.7 ± 2.0 for the exclusion (PL) and inclusion (PLW) of water ligands, respectively. As reported in this study, ligands (e.g. – carboxyl groups) are monodentate unless specifically identified as bidentate, i.e. comprising two ligand atoms. Water occupancies in the crystalline structures are considered approximations. The distribution of CN by site (Fig. 2d) indicates that binding was most commonly observed with two, or to a lesser extent, four ligands. Interestingly, nine sites were reported with only a single amino acid ligand atom for coordination when water was excluded, and three of these were unchanged even with the inclusion of oxygen ligands from water.

The distribution of CN values in Table 1 is further divided into percentages falling between the ranges of 2 to 5 ligands (77.1%) and 6 to 9 ligands (16.7%). The CN range of 2 to 5 was selected for two reasons. First, previous studies have indicated that Pb2+ may adopt a binding structure similar to Zn2+, using 4 to 6 binding ligands, as a result of ionic displacement [68, 69]. Second, a study of crystalline structure data in the Cambridge Structural Database by Shimoni-Livny et al. [70] observed two general geometries for Pb2+-binding: a holodirected, spherical geometry comprised of 9 to 10 ligands (Fig. 2b) and a hemidirected geometry where 2 to 5 coordination ligands occupy only half of a sphere (Fig. 2c). It is notable that a hemidirected or planar geometry was also observed in nearly 28% of the Non-EF-Hand Ca2+ binding sites surveyed in our recent statistical analysis [M. Kirberger and J.J. Yang, manuscript in preparation], indicating that this geometry is not confined to Pb2+-binding.

Alternatively, the CN range of 6 to 9 was selected both for comparison with Ca2+-binding (6 to 8 ligands) [71] and because previous studies with small molecules suggested a coordination number of 6.9 for Pb2+ [4]. The results of this analysis indicate that binding coordination of Pb2+, based on number of ligands, is more closely-related to that of Zn2+ than Ca2+. This is particularly apparent with respect to the EF-Hand Ca2+-binding sites which average 6 to 8 ligands in well-ordered structures. These results, which conflict with conclusions reported from studies of small molecules, are, however, consistent with hard-soft acid models for metals. Ca2+ is classified as a hard Lewis acid (Table S3) with an ionic radius of 0.99Å – 1.12 Å for a typical coordination number of 6 to 8 based on studies of small molecules [4, 19]. Conversely, Pb2+ has a reported ionic radius of 1.12 Å – 1.19 Å for similar coordination. Both Pb2+ and Zn2+ are classified as borderline acids, exhibiting properties of both hard and soft acids, so it is reasonable to assume that Pb2+ may share more similar binding features with Zn2+ than Ca2+.

3.2 Charge by Binding Site

The Relative % Distribution of charge between the two datasets is shown in Fig. 3a, indicating a range from 0 to −4 in the binding site, with a mean negative charge of 1.7 ± 1.1 for DS Final (Table 1). The mean and net charge values reported for the metal binding sites do not reflect positive charge contribution from the divalent cation. Previous studies of Ca2+ have indicated that higher binding affinities are found with a net negative charge within 5–15 Å of the ion [72, 73], and a microenvironment containing 3–4 negative charges likely represents an optimal charge configuration [67, 74]. However, a more recent study in our laboratory indicates that this is representative of the more highly-structured EF-Hand proteins. The rounded net negative charge for Pb2+-binding sites (2 ± 1) falls between the structurally more diverse Non-EF-Hand proteins (1 ± 1) and the EF-Hand proteins (3 ± 1). Charge interactions for Pb2+ are likely stabilized due to the higher electronegativity (Table S3) and increased potential for partial covalent bond formation of Pb2+, so that it is less structurally-constrained and can bind more opportunistically than Ca2+.

Fig. 3.

Fig. 3

(a) Relative % distribution of charge values for Pb2+-binding sites from DS HR and DS Final, and Ca2+-binding sites for Non-EF-Hand and EF-Hand proteins. (b) Distribution of CN values by type for six Pb2+-binding sites containing sulfur ligands. Other AA in the figure represents ligand atoms other than sulfur from amino acids.

3.3 Binding Ligands

Oxygen atoms from amino acids represent the major binding ligand for Pb2+ (118), followed by oxygen from water (36), sulfur (13) and nitrogen (10) (Table 1). The % Relative Distribution of ligand atoms shown in Fig. 4a indicates that binding ligand preference for Pb2+ followed the order sidechain Glu (38.4%) > sidechain Asp (20.3%) = water (20.3%) > Sulfur (7.3%). For comparison, the distributions of ligand preference for EF-Hand and Non-EF-Hand Ca2+-binding proteins are presented in Fig. 4b and 4c, respectively. From these figures, it can be seen that Pb2+ differs in several significant ways from Ca2+-binding. The increased use of sidechain Glu by Pb2+ (38.4%) followed by sidechain Asp (20.3%) contrasts sharply with trends observed in both the highly-structured EF-Hand sites (sidechain Asp, 29.7%; sidechain Glu 26.6%) and the more structurally-diverse Non-EF-Hand sites (sidechain Asp, 24.5%; sidechain Glu, 10.4%). The presence of water in the Pb2+ sites falls roughly in the middle of the two Ca2+-binding classes, but utilization of carbonyl oxygen atoms by Pb2+ is considerably lower than both the EF and Non-EF Ca2+-binding classes (Fig. 4).

Fig. 4.

Fig. 4

Percent distribution of ligands for (a) Pb2+, (b) EF-Hand Ca2+ and (c) Non-EF-Hand Ca2+ binding sites, where: SC indicates sidechain; MC indicates mainchain; O, N, S indicates oxygen, nitrogen, and sulfur, respectively, and; HOH represents ligand oxygen from water.

Table 1 also summarizes the mean binding distance values determined from the analysis. The Pb-O distance (for amino acids) was found to be 2.7 ± 0.4 Å, which is slightly higher than the mean of 2.4 ± 0.2 Å reported for Ca-O. The mean distances reported for Pb-O (water), Pb-N and Pb-S were 2.8 ± 0.4 Å, 2.6 ± 0.4 Å, and 3.2 ± 0.3 Å, respectively. Except for Pb-S, these values were nearly identical despite expectations that Pb-N would exhibit a longer binding distance based on a comparison with data from Sarret et al. [62], where ranges for Pb-O, Pb-N and Pb-S were reported as 2.2–4.2 Å, 3.0–4.2 Å, and 2.6–3.4 Å, respectively.

Nitrogen is generally accepted as a binding ligand for Pb2+, and marginally for Ca2+, with small molecules; however, in our detailed statistical analysis of protein calcium binding sites [M. Kirberger and J.J. Yang, manuscript in preparation], less than 1% of all identified potential ligands were nitrogen atoms, and the limited contribution by nitrogen to bind Pb2+ in proteins is clear in Fig. 4a. Only ten nitrogen atoms were identified as potential ligands within a cutoff distance of 3.5 Å. Nine of these were from side-chains, with six from His, two from Lys and one from Gln. Although the low pKa (6.0) for His makes it a suitable binding ligand, Lys is unlikely to function as a binding ligand as its pKa is significantly higher than physiological pH. For Gln, and presumably Asn, it is more likely to assume that binding of Pb2+ would occur with the polar, uncharged –CO(NH2) functional group, rather than the isolated sidechain nitrogen, due to the conjugated π–bond system and the planar structure of the group resulting from resonance. It can be inferred from these data that nitrogen plays a more limited role in the binding of Pb2+ to proteins than what has been reported in the case of small molecules.

Additionally, since Pb2+ was previously reported by Magyar and Andersen [47, 52] to bind in a thiol-rich site with a tendency to adopt a three ligand, trigonal pyramidal geometry, we attempted to evaluate the limited data available for sulfur ligands. As shown in Fig. 3b, data were available for only six Pb2+-binding sites which included sulfur ligands, where coordination number values reported were 1, 2, 4 and 6, with binding by 4 ligands apparent in three of the six sites. A trigonal pyramidal geometry for Pb2+ was not observed in our study; however this may be due to fact that the structures in our limited dataset were not identical to those reported by Magyar and Andersen.

3.4 Structural Analysis

Next we evaluated structural changes associated with the displacement of Ca2+ by Pb2+ in the EF-Hand protein CaM. CaM, like most EF-Hand proteins, exhibits an irregular pentagonal-bipyramidal geometry (Fig. 2a), with 5 planar ligands at −Z, Y, Z, and −Y, where −Z is a bidentate ligand. Ligands at X and −X are typically oxygen atoms from a side-chain carboxyl group and a bound water molecule, respectively. CaM also has high sequence similarity between species. An alignment for PDB proteins 3cln, 1exr, and 1n0y using ClustalW (http://www.ebi.ac.uk/clustalw/) indicates that the Ca2+- and Pb2+-bound complexes of CaM (1exr.pdb and 1n0y.pdb) share 100% sequence similarity except for an additional Ala at the N-terminal, and a Lys at the C-terminal in 1n0y, and both are 88% homologous to 3cln (Supplementary, Fig. S1). The structures of Ca2+ -CaM (1exr) and Pb2+ -CaM (1n0y) in Fig. 1a and Fig. 1b, respectively, were compared by Wilson et al. [75], who reported a Cα RMSD of 2.1 Å in the N-terminal domain compared with 1.1 Å in the C-terminal domain, with the most apparent deviation occurring between the N-terminal helix A and the C-terminal half of helix D/E. Additionally, Fig. 1c shows that 14 Pb2+ ions are bound in the crystalline structure of CaM (1n0y), such that Pb2+ ions have not only replaced Ca2+ ions in the binding pockets, but have also become bound to surface ligands.

The pronounced global conformational changes observed in Fig. 1c for Pb2+ bound CaM indicate new folding that is not observed in the Ca2+ bound form. An electrostatic potential surface map of protein 1n0y generated using DelPhi and GRASP (Fig. 1d) [7679] shows an area of concentrated negative charge in the folding groove between Chains A and B where the 4 Pb2+ ions appear bound in the structure. However, the backbone RMSD comparing sites EF-I through EF-IV in the two structures, calculated using Sybyl software (Tripos, St. Louis, MO), indicated RMSD values ranging from 0.12 in EF-III, to 0.35 in EF-IV (Table 2). This suggests minimal disruption of the site due to ion displacement. To further validate this, a Ramachandran plot generated by VADAR [80] for 1n0y revealed that all dihedral angles fall within allowed regions, indicating no apparent strain on the backbone associated with binding of Pb2+. The limited perturbation in the binding sites and the secondary binding of Pb2+ coincident with regions of high electrostatic potential strongly suggest that the observed conformational changes are independent of ion displacement, but related instead to our proposed mechanism of opportunistic binding which would imply much stronger binding affinity for the Pb2+ ions than what is typically observed with low affinity, non-specific binding of metals at high concentrations.

Table 2.

Summary of angle/distance values for 1exr and 1n0y.

EF-I EF-II EF-III EF-IV Mean
1EXR total Ca2+ ligands 6 6 6 6 6
1N0Y total Pb2+ ligands 7 8 6 7 7
Mean sum Δ Binding Distance CaPb (Å) 0.14 0.08 0.01 0.08 0.08
Mean sum Δ CLI Angle CaPb (°) −8.67 −5.38 −1.34 −4.62 −5.00
RMSD by site 0.28 0.28 0.12 0.35 0.26 ± 0.10
Ca2+ planar monodentate LIL angles (°) 78.14 ± 3.34 78.05 ± 3.08 77.07 ± 1.75 78.76 ± 1.59 78.00 ± 2.37
Pb2+ planar monodentate LIL angles (°) 78.95 ± 5.86 75.80 ± 4.74 77.12 ± 2.00 78.70 ± 5.89 77.64 ± 4.57
Ca2+ planar bidentate LIL angles (°) 53.01 51.48 52.30 52.35 52.29 ± 0.63
Pb2+ planar bidentate LIL angles (°) 50.84 46.49 51.77 48.99 49.52 ± 2.33
Ca2+ Ion Dihedral (°) 4.91 4.12 7.43 0.23 4.17 ± 2.98
Pb2+ Ion Dihedral (°) 20.76 26.03 21.10 11.79 19.92 ± 5.93
Distance of Ca2+ ion out of bidentate plane 0.24 0.21 0.37 0.01 0.21 ± 0.15
Distance of Pb2+ ion out of bidentate plane 1.01 1.36 1.02 0.61 1.00 ± 0.31

CLI: Carbon-Ligand-Ion. LIL: Ligand-Ion-Ligand.

Consistent with this, a comparison of paired models (Fig. 5: ab, cd, ef, gh) corresponding to EF sites I–IV for Ca2+-binding and Pb2+-binding indicates that the basic geometry for binding of Ca2+ is conserved upon binding with Pb2+, and the same binding ligands, with minor exceptions, are used by both ions (Table S4). A comparison of distance and angle values for binding ligands utilized by both ions (Table S4) shows a negligible, mean net increase in the binding distance (0.08 Å) and a corresponding mean sum decrease in the C-Lig-Ion angle (−5.00 º) for Pb2+, but the monodentate and bidentate carbon-ligand-ion angles were nearly identical, and in both cases, the mean differences fall within the range of the standard deviation, so they are in all probability not statistically different. The data associated with the bidentate dihedral angles for Ca2+-binding, as summarized in Table 2, correlate well with research reported by McPhalen [81] that indicated a mean distance of 0.4 Å for the Ca2+ ion out of the carboxlyate plane, with a φ angle under 30°. For Pb2+, however, the mean average distance for the ion increases to 1.00 ± 0.31 Å from 0.21 ± 0.15 Å observed for Ca2+, and the mean bidentate ligand dihedral (φ) angle was much larger for the Pb2+ ion (19.92 ± 5.93º) than for Ca2+ (4.17 ± 2.98º) (Fig. 6a).

Fig. 5.

Fig. 5

Paired binding sites EF-I (ab) EF-II (cd) EF-III (ef) and EF-IV (gh) for PDB proteins 1exr (left) and 1n0y (right).

Fig. 6.

Fig. 6

(a) Illustration of position of the Pb2+ ion (left) and the Ca2+ (right) with respect to the carboxlyate bidentate plane. D and f indicate distance and angle of ion relative to plane formed by C, Od1 and Od2. (b) Positions of Ca2+ ion (top) and Pb2+ ion (bottom) with respect to pentagonal plane. (c) Example illustrating comparison of Ca2+- and Pb2+-binding characteristics with respect to the pentagonal plane. DCa and DPb indicate ion distance out of pentagonal plane. (d) Comparison of a binding site from ALAD protein showing Zn2+-binding in 1eb3.pdb (top) and Pb2+-binding in 1qnv (bottom) where one additional ligand (Ser179) is provided for binding of Pb2+.

Mean values of 6 and 7 coordination ligands (excluding water) were found for Ca2+ and Pb2+ respectively (Table 2), indicating that Pb2+ may take advantage of additional proximate ligand oxygen atoms when available, without disruption to the binding site. Nitrogen atoms potentially available as sidechain ligands in the binding loop sequence (Asn60 and Asn97; Figs. 5d and 5f, respectively) do not appear to be involved in binding, although there are no apparent barriers restricting rotation of the amide group around the Cγ-Cβ bond. This may, however, be due to mislabeling of atoms in the original structure.

For comparative purposes, two structures of yeast 5-aminolaevulinic acid dehydratase (ALAD) from Saccharomyces cerevisiae bound with Zn2+ (1eb3.pdb) and Pb2+ (1qnv.pdb) were also evaluated for changes associated with ionic displacement by Pb2+ (Fig. 6). ALAD is a 280-kDa protein comprised of eight identical subunits that each bind a single Zn2+ ion. A single subunit from Chain A is presented in PDB files 1eb3 and 1qnv. Previous work by Bergdahl identified ALAD as the protein binding Pb2+ in human erythrocytes, where 99% of free Pb2+ concentrates in the blood [82], and the relationship between Pb2+ toxicity and human ALAD has been well-established [83].

Data from a structural analysis are summarized in Table S5, which demonstrates strong similarity to changes observed in the EF-Hand binding sites for CaM. Distortion of the binding site is observed based on a mean increase in the binding distances of the three Cys thiol ligands (0.54 Å) and decreasing carbon-ligand-ion (CLI) angles for Cys133 and Cys135 (Table S5) which is consistent with the larger radius of Pb2+. Additionally, the carbonyl oxygen of Ser179 which does not appear to be a binding ligand for Zn2+ (Fig. 6d, top) is reoriented 0.9 Å to interact with the Pb2+ ion (Fig. 6d, bottom). The binding site is formed in a deep pocket where interestingly, a second Pb2+ ion is bound 4.40 Å from the ion occupying the binding site, sharing the SG sulfur ligand from Cys143, whereas only a single Zn2+ ion is bound in the 1eb3 ALAD structure. Generation of an electrostatic potential map with Sybyl did not indicate dense charge clustering in this region, possibly due to the buried nature of the site.

Erskine et al., who deposited the structure 1qnv.pdb, reported a RMSD value of 0.4 for 326 matched Cα atoms [84]. Calculations with Sybyl for the resolved structural region indicated a backbone RMSD of 0.58 for the structure comprising residues 133–179 and a backbone RMSD value of 1.43 for the structure comprising residues 1–219. As was seen with the displacement of Ca2+, disruption of the backbone in the binding site microenvironment appeared minimal as a result of Pb2+-binding.

Based on the results of our analysis, Fig. 6 illustrates characteristics of a proposed model showing the differences between Ca2+ and Pb2+ during binding. In this model, which includes parameters that may be extensible to Zn2+-binding sites, the slightly larger ionic radius of Pb2+ is accommodated by small changes in side chain ligand orientations, increased displacement of the ion (DPb) relative to the Ca2+ occupancy (DCa) of the site (Fig. 6c), and more pronounced reorientation of the Glu anchor at −Z (Fig. 6a). This would account for the apparent minimal distortion in the pentagonal plane (Fig. 6b) and more significantly, the backbone. This proposed model accounts for the larger ionic radius of Pb2+, minor rotation of the side-chains, the net increase in binding distance and net decrease in bond angles when binding Pb2+ (Table 2), and the increase observed in the bidentate ligand dihedral (f) angle for the Pb2+ ion. It is also consistent with previously-noted observations indicating that Pb2+ initially activates then deactivates CaM with increasing Pb2+ concentration, where activation of CaM results from ionic displacement, followed by strong opportunistic binding to effect conformational changes.

4 Conclusions

It is apparent from both the structural and database analyses of Pb2+-binding sites that oxygen is the dominant binding ligand for Pb2+, or sulfur in the case of Zn2+-binding sites, with only negligible interaction between Pb2+ and nitrogen. The Pb2+ binding sites were significantly different from those observed for EF-Hand proteins, requiring fewer coordinating ligands and less negative charge, but sharing more structural similarity with the more disordered Non-EF-Hand sites. Conversely, the increased utilization by Pb2+ of Glu (38.4%) over Asp (20.3%) reverses the trend observed for Non-EF-Hand CaBPs (10.4% and 24.5%, respectively), indicating differences in the two binding models not accounted for solely by ionic charge and atom type. Moreover, the significant structural alterations in CaM appear to be due to binding of Pb2+ in regions of high surface negative charge potential (Fig. 1c), rather than exchange of Ca2+ with Pb2+, which is supported by the low RMSD values reported for ionic displacement (Table 2). The combination of these results, and previous studies citing the initial activation and subsequent inhibition of CaM as a function of toxic metal concentration [2732], argues that strong opportunistic binding, either coupled with, or independent of, ionic displacement, has several important ramifications with respect to toxicity. First, proteins may bind both opportunistically and by ionic displacement, resulting in activation or inhibition of the protein as a function of metal concentration. Studies of CaM showing initial activation followed by inhibition in response to increasing concentration of metal ion (e.g. − Pb2+) suggests that initial binding in the active sites may first activate the protein as if bound with Ca2+, but the subsequent deactivation may result from more pronounced conformational changes resulting from additional opportunistic binding. Second, strong non-specific or opportunistic binding can potentially increase solubility and facilitate transport and diffusion of toxic metals, as may be the case with ALAD from human blood erythrocytes, which may potentially bind multiple Pb2+ ions in a site normally occupied by a single Zn2+ ion.

Furthermore, the apparent, promiscuous binding of Pb2+ is suggested by the variety of ions it can displace (Table S2), its adaptability to different coordination geometries, and the wide range of coordination numbers and charge values associated with opportunistic binding in the absence of well-defined binding sites. Additionally, recently reported studies indicate that bacterial proteins encode different binding motifs in sensors capable of detecting Pb2+. CmtR, a Cd2+/Pb2+ regulator expressed in Mycobacterium tuberculosis, binds Pb2+ with three Cys thiols, more typical of Zn2+ binding [85]. However, in Ralstonia metallidurans strain CH34, a Cys ligand is replaced by two Glu residues, resulting in a binding motif more similar to that of Ca2+ [36]. It is presumed that the ability of Pb2+ to bind opportunistically may extend to non-metalloproteins, thus increasing the number of potential target proteins whose function may be altered due to the introduction of toxic metals.

Supplementary Material

01
02

Acknowledgments

The authors would like to thank Dr. Wei Yang from NIH for helpful suggestions, and Ning Chen, Dr. Jin Zou and Dan Adams for their critical review of the manuscript. Thanks also to Dr. Hsiau-Wei Lee and Jie Jiang for helpful instructions on the use of Sybyl and DelPhi software. Special thanks to Dr. Robert Kretsinger for his very helpful review, comments and criticisms during preparation of this manuscript. Funding for this work was in part provided by NIH Grants GM070555, GM 62999-1 and AHA to JJY.

Abbreviations

CaBP

Calcium-Binding Protein

CaM

calmodulin

CN

Coordination Number

DS

Dataset

FC

Formal Charge

HR

High Resolution

LPC

Ligand Protein Contact Data Server

PDB

Protein Data Bank

PL

Protein Ligands

PLW

Protein Ligands and Water

RMSD

root-mean-squared deviation

Footnotes

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  • 1.Ibers JA, Holm RH. Science. 1980;209:223–235. doi: 10.1126/science.7384796. [DOI] [PubMed] [Google Scholar]
  • 2.Holm RH, Kennepohl P, Solomon EI. Chem Rev. 1996;96:2239–2314. doi: 10.1021/cr9500390. [DOI] [PubMed] [Google Scholar]
  • 3.Tainer JA, Roberts VA, Getzoff ED. Curr Opin Biotechnol. 1992;3:378–387. doi: 10.1016/0958-1669(92)90166-g. [DOI] [PubMed] [Google Scholar]
  • 4.Glusker JP. Adv Protein Chem. 1991;42:1–76. doi: 10.1016/s0065-3233(08)60534-3. [DOI] [PubMed] [Google Scholar]
  • 5.Silva JRRFd, Williams RJP. The biological chemistry of the elements : the inorganic chemistry of life. Clarendon Press ;Oxford University Press; Oxford [England] New York: 1991. [Google Scholar]
  • 6.Lippard SJ, Berg JM. Principles of bioinorganic chemistry. University Science Books; Mill Valley, Calif.: 1994. [Google Scholar]
  • 7.Yamashita MM, Wesson L, Eisenman G, Eisenberg D. Proc Natl Acad Sci U S A. 1990;87:5648–5652. doi: 10.1073/pnas.87.15.5648. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Bagley SC, Altman RB. Protein Sci. 1995;4:622–635. doi: 10.1002/pro.5560040404. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Babor M, Greenblatt HM, Edelman M, Sobolev V. Proteins. 2005;59:221–230. doi: 10.1002/prot.20431. [DOI] [PubMed] [Google Scholar]
  • 10.Dudev T, Lim C. Chemical Reviews. 2003;103:773–787. doi: 10.1021/cr020467n. [DOI] [PubMed] [Google Scholar]
  • 11.Dudev T, Lin YL, Dudev M, Lim C. J Am Chem Soc. 2003;125:3168–3180. doi: 10.1021/ja0209722. [DOI] [PubMed] [Google Scholar]
  • 12.Einspahr H, Bugg CE, Sigel H. In: Calcium and its role in biology, 17, Crystal Structure Studies of Calcium Complexes and Implications for Biological Systems. Dekker M, editor. New York: 1984. pp. 52–97. [Google Scholar]
  • 13.Harding MM. Acta Crystallogr D Biol Crystallogr. 1999;55:1432–1443. doi: 10.1107/s0907444999007374. [DOI] [PubMed] [Google Scholar]
  • 14.Harding MM. Acta Crystallogr D Biol Crystallogr. 2000;56:857–867. doi: 10.1107/s0907444900005849. [DOI] [PubMed] [Google Scholar]
  • 15.Herzberg O, Moult J, James MN. J Biol Chem. 1986;261:2638–2644. [PubMed] [Google Scholar]
  • 16.Holmes KC, Popp D, Gebhard W, Kabsch W. Nature. 1990;347:44–49. doi: 10.1038/347044a0. [DOI] [PubMed] [Google Scholar]
  • 17.Carafoli E. J Hypertens Suppl. 1994;12:S47–56. [PubMed] [Google Scholar]
  • 18.Santella L, Carafoli E. Faseb J. 1997;11:1091–1109. [PubMed] [Google Scholar]
  • 19.Martin R. Bioinorganic Chemistry of Calcium. Marcel Dekker; New York: 1984. [Google Scholar]
  • 20.Nelson MR, Chazin WJ. Protein Sci. 1998;7:270–282. doi: 10.1002/pro.5560070206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Tajima M, Urabe I, Yutani K, Okada H. Eur J Biochem. 1976;64:243–247. doi: 10.1111/j.1432-1033.1976.tb10293.x. [DOI] [PubMed] [Google Scholar]
  • 22.Forsen S, Thulin E, Lilja H. FEBS Lett. 1979;104:123–126. doi: 10.1016/0014-5793(79)81097-2. [DOI] [PubMed] [Google Scholar]
  • 23.Mills JSJJ. J Biol Chem. 1985;260:15100–15105. [PubMed] [Google Scholar]
  • 24.Wang CL, Leavis PC, Gergely J. Biochemistry. 1984;23:6410–6415. doi: 10.1021/bi00321a020. [DOI] [PubMed] [Google Scholar]
  • 25.Pidcock E, Moore GR. J Biol Inorg Chem. 2001;6:479–489. doi: 10.1007/s007750100214. [DOI] [PubMed] [Google Scholar]
  • 26.Yang W, Wilkins AL, Ye Y, Liu ZR, Li SY, Urbauer JL, Hellinga HW, Kearney A, van der Merwe PA, Yang JJ. J Am Chem Soc. 2005;127:2085–2093. doi: 10.1021/ja0431307. [DOI] [PubMed] [Google Scholar]
  • 27.Chao SH, Suzuki Y, Zysk JR, Cheung WY. Mol Pharmacol. 1984;26:75–82. [PubMed] [Google Scholar]
  • 28.Ferguson C, Kern M, Audesirk G. Neurotoxicology. 2000;21:365–378. [PubMed] [Google Scholar]
  • 29.Chao SH, Bu CH, Cheung WY. Arch Toxicol. 1995;69:197–203. doi: 10.1007/s002040050158. [DOI] [PubMed] [Google Scholar]
  • 30.Suzuki Y, Chao SH, Zysk JR, Cheung WY. Arch Toxicol. 1985;57:205–211. doi: 10.1007/BF00290889. [DOI] [PubMed] [Google Scholar]
  • 31.Habermann E, Crowell K, Janicki P. Arch Toxicol. 1983;54:61–70. doi: 10.1007/BF00277816. [DOI] [PubMed] [Google Scholar]
  • 32.Kern M, Wisniewski M, Cabell L, Audesirk G. Neurotoxicology. 2000;21:353–363. [PubMed] [Google Scholar]
  • 33.Busenlehner LS, Giedroc DP. J Inorg Biochem. 2006;100:1024–1034. doi: 10.1016/j.jinorgbio.2006.01.002. [DOI] [PubMed] [Google Scholar]
  • 34.Fahmy K, Merroun M, Pollmann K, Raff J, Savchuk O, Hennig C, Selenska-Pobell S. Biophys J. 2006;91:996–1007. doi: 10.1529/biophysj.105.079137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Ye J, Kandegedara A, Martin P, Rosen BP. J Bacteriol. 2005;187:4214–4221. doi: 10.1128/JB.187.12.4214-4221.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Borremans B, Hobman JL, Provoost A, Brown NL, van Der Lelie D. J Bacteriol. 2001;183:5651–5658. doi: 10.1128/JB.183.19.5651-5658.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Hernandez-Ochoa I, Garcia-Vargas G, Lopez-Carrillo L, Rubio-Andrade M, Moran-Martinez J, Cebrian ME, Quintanilla-Vega B. Reprod Toxicol. 2005;20:221–228. doi: 10.1016/j.reprotox.2005.01.007. [DOI] [PubMed] [Google Scholar]
  • 38.Apostoli P, Bellini A, Porru S, Bisanti L. Am J Ind Med. 2000;38:310–315. doi: 10.1002/1097-0274(200009)38:3<310::aid-ajim10>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  • 39.Despres C, Beuter A, Richer F, Poitras K, Veilleux A, Ayotte P, Dewailly E, Saint-Amour D, Muckle G. Neurotoxicol Teratol. 2005;27:245–257. doi: 10.1016/j.ntt.2004.12.001. [DOI] [PubMed] [Google Scholar]
  • 40.Chetty CS, Reddy GR, Murthy KS, Johnson J, Sajwan K, Desaiah D. Int J Toxicol. 2001;20:113–120. doi: 10.1080/109158101317097692. [DOI] [PubMed] [Google Scholar]
  • 41.Reddy GR, Zawia NH. Int J Dev Neurosci. 2000;18:791–795. doi: 10.1016/s0736-5748(00)00048-4. [DOI] [PubMed] [Google Scholar]
  • 42.Moore MR, Goldberg A, Yeung-Laiwah AA. Ann N Y Acad Sci. 1987;514:191–203. doi: 10.1111/j.1749-6632.1987.tb48774.x. [DOI] [PubMed] [Google Scholar]
  • 43.Atchison WD. J Bioenerg Biomembr. 2003;35:507–532. doi: 10.1023/b:jobb.0000008023.11211.13. [DOI] [PubMed] [Google Scholar]
  • 44.Chao SH, Bu CH, Cheung WY. Arch Toxicol. 1990;64:490–496. doi: 10.1007/BF01977632. [DOI] [PubMed] [Google Scholar]
  • 45.Markovac J, Goldstein GW. Nature. 1988;334:71–73. doi: 10.1038/334071a0. [DOI] [PubMed] [Google Scholar]
  • 46.Bouton CM, Frelin LP, Forde CE, Arnold Godwin H, Pevsner J. J Neurochem. 2001;76:1724–1735. doi: 10.1046/j.1471-4159.2001.00168.x. [DOI] [PubMed] [Google Scholar]
  • 47.Andersen RJ, diTargiani RC, Hancock RD, Stern CL, Goldberg DP, Godwin HA. Inorg Chem. 2006;45:6574–6576. doi: 10.1021/ic060497z. [DOI] [PubMed] [Google Scholar]
  • 48.Harding MM. Acta Crystallogr D Biol Crystallogr. 2004;60:849–859. doi: 10.1107/S0907444904004081. [DOI] [PubMed] [Google Scholar]
  • 49.Koca J, Zhan CG, Rittenhouse RC, Ornstein RL. J Comput Chem. 2003;24:368–378. doi: 10.1002/jcc.10217. [DOI] [PubMed] [Google Scholar]
  • 50.Erskine PT, Senior N, Awan S, Lambert R, Lewis G, Tickle IJ, Sarwar M, Spencer P, Thomas P, Warren MJ, Shoolingin-Jordan PM, Wood SP, Cooper JB. Nat Struct Biol. 1997;4:1025–1031. doi: 10.1038/nsb1297-1025. [DOI] [PubMed] [Google Scholar]
  • 51.Jaffe EK, Martins J, Li J, Kervinen J, Dunbrack RL., Jr J Biol Chem. 2001;276:1531–1537. doi: 10.1074/jbc.M007663200. [DOI] [PubMed] [Google Scholar]
  • 52.Magyar JS, Weng TC, Stern CM, Dye DF, Rous BW, Payne JC, Bridgewater BM, Mijovilovich A, Parkin G, Zaleski JM, Penner-Hahn JE, Godwin HA. J Am Chem Soc. 2005;127:9495–9505. doi: 10.1021/ja0424530. [DOI] [PubMed] [Google Scholar]
  • 53.Yang JJ, Gawthrop A, Ye Y. Protein Pept Lett. 2003;10:331–345. doi: 10.2174/0929866033478852. [DOI] [PubMed] [Google Scholar]
  • 54.Nelson MR, Thulin E, Fagan PA, Forsen S, Chazin WJ. Protein Sci. 2002;11:198–205. doi: 10.1110/ps.33302. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Strynadka NC, James MN. Annu Rev Biochem. 1989;58:951–998. doi: 10.1146/annurev.bi.58.070189.004511. [DOI] [PubMed] [Google Scholar]
  • 56.Yap KL, Kim J, Truong K, Sherman M, Yuan T, Ikura M. J Struct Funct Genomics. 2000;1:8–14. doi: 10.1023/a:1011320027914. [DOI] [PubMed] [Google Scholar]
  • 57.Fullmer CS, Edelstein S, Wasserman RH. J Biol Chem. 1985;260:6816–6819. [PubMed] [Google Scholar]
  • 58.Ouyang H, Vogel HJ. Biometals. 1998;11:213–222. doi: 10.1023/a:1009226215543. [DOI] [PubMed] [Google Scholar]
  • 59.Kretsinger RH, Nockolds CE. J Biol Chem. 1973;248:3313–3326. [PubMed] [Google Scholar]
  • 60.Zhou Y, Yang W, Kirberger M, Lee HW, Ayalasomayajula G, Yang JJ. Proteins. 2006;65:643–655. doi: 10.1002/prot.21139. [DOI] [PubMed] [Google Scholar]
  • 61.Kawasaki H, Nakayama S, Kretsinger RH. Biometals. 1998;11:277–295. doi: 10.1023/a:1009282307967. [DOI] [PubMed] [Google Scholar]
  • 62.Sarret G, Manceau A, Spadini L, Roux JC, Hazemann JL, Soldo Y, Eybert-Berard L, Menthonnex JJ. Environ Sci Technol. 1998;32:1648–1655. [Google Scholar]
  • 63.Harding MM. Acta Crystallogr D Biol Crystallogr. 2002;58:872–874. doi: 10.1107/s0907444902003712. [DOI] [PubMed] [Google Scholar]
  • 64.Swain AL, Kretsinger RH, Amma EL. J Biol Chem. 1989;264:16620–16628. [PubMed] [Google Scholar]
  • 65.Cruickshank DW. Acta Crystallogr D Biol Crystallogr. 1999;55:583–601. doi: 10.1107/s0907444998012645. [DOI] [PubMed] [Google Scholar]
  • 66.DeLano WL. The PyMOL Molecular Graphics System. 2002. [Google Scholar]
  • 67.Marsden BJ, Shaw GS, Sykes BD. Biochem Cell Biol. 1990;68:587–601. doi: 10.1139/o90-084. [DOI] [PubMed] [Google Scholar]
  • 68.Godwin HA. Current Opinion in Chemical Biology. 2001;5:223–227. doi: 10.1016/s1367-5931(00)00194-0. [DOI] [PubMed] [Google Scholar]
  • 69.Battistuzzi G, Borsari M, Menabue L, Saladini M, Sola M. Inorg Chem. 1996;35:4239–4247. doi: 10.1021/ic950599h. [DOI] [PubMed] [Google Scholar]
  • 70.Shimoni-Livny L, Glusker JP, Bock CW. Inorganic Chemistry. 1998;37:1853–1867. [Google Scholar]
  • 71.Yang W, Lee HW, Hellinga H, Yang JJ. Proteins. 2002;47:344–356. doi: 10.1002/prot.10093. [DOI] [PubMed] [Google Scholar]
  • 72.Linse S, Brodin P, Johansson C, Thulin E, Grundstrom T, Forsen S. Nature. 1988;335:651–652. doi: 10.1038/335651a0. [DOI] [PubMed] [Google Scholar]
  • 73.Linse S, Forsen S. Adv Second Messenger Phosphoprotein Res. 1995;30:89–151. doi: 10.1016/s1040-7952(05)80005-9. [DOI] [PubMed] [Google Scholar]
  • 74.Yang W, Jones LM, Isley L, Ye Y, Lee HW, Wilkins AL, Liu ZR, Hellinga HW, Malchow R, Ghazi M, Yang JJ. Journal of the American Chemical Society. 2003;125:6165–6171. doi: 10.1021/ja034724x. [DOI] [PubMed] [Google Scholar]
  • 75.Wilson MA, Brunger AT. Acta Crystallogr D Biol Crystallogr. 2003;59:1782–1792. doi: 10.1107/s0907444903016846. [DOI] [PubMed] [Google Scholar]
  • 76.Honig B, Nicholls A. Science. 1995;268:1144–1149. doi: 10.1126/science.7761829. [DOI] [PubMed] [Google Scholar]
  • 77.Rocchia W, Alexov E, Honig B. Journal of Physical Chemistry B. 2001;105:6507–6514. [Google Scholar]
  • 78.Gilson MK, Honig B. Proteins. 1988;4:7–18. doi: 10.1002/prot.340040104. [DOI] [PubMed] [Google Scholar]
  • 79.Nicholls A, Honig B. J Comp Chem. 1991;12:435–445. [Google Scholar]
  • 80.Willard L, Ranjan A, Zhang H, Monzavi H, Boyko RF, Sykes BD, Wishart DS. Nucleic Acids Res. 2003;31:3316–3319. doi: 10.1093/nar/gkg565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.McPhalen CA, Strynadka NC, James MN. Adv Protein Chem. 1991;42:77–144. doi: 10.1016/s0065-3233(08)60535-5. [DOI] [PubMed] [Google Scholar]
  • 82.Bergdahl IA, Grubb A, Schutz A, Desnick RJ, Wetmur JG, Sassa S, Skerfving S. Pharmacol Toxicol. 1997;81:153–158. doi: 10.1111/j.1600-0773.1997.tb02061.x. [DOI] [PubMed] [Google Scholar]
  • 83.Kelada SN, Shelton E, Kaufmann RB, Khoury MJ. Am J Epidemiol. 2001;154:1–13. doi: 10.1093/aje/154.1.1. [DOI] [PubMed] [Google Scholar]
  • 84.Erskine PT, Duke EM, Tickle IJ, Senior NM, Warren MJ, Cooper JB. Acta Crystallogr D Biol Crystallogr. 2000;56:421–430. doi: 10.1107/s0907444900000597. [DOI] [PubMed] [Google Scholar]
  • 85.Wang Y, Hemmingsen L, Giedroc DP. Biochemistry. 2005;44:8976–8988. doi: 10.1021/bi050094v. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

01
02

RESOURCES